Clinical trial
Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and…
NCT00285662 · Papua New Guinea Institute of Medical Research, Other · Completed
Key facts
| NCT number | NCT00285662 |
|---|---|
| Title | Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants |
| Official title | Intermittent Preventive Treatment (IPTi) for the Prevention of Malaria and Anaemia in PNG Infants |
| Lead sponsor | Papua New Guinea Institute of Medical Research, Other |
| Collaborators | University of Melbourne Case Western Reserve University |
| Status | Completed |
| Study type | Interventional |
| Conditions | Malaria, Anemia |
| Intervention type | Drug |
| Interventions | Amodiaquine/sulphadoxine-pyrimethamine, Artesunate/sulphadoxine-pyrimethamine or placebo |
| Enrollment | 1,100 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Feb 2, 2006 |
| Last update posted | Jul 25, 2011 |
| Countries | Papua New Guinea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: